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Early reports often ignored pain as an important symptom in multiple sclerosis (MS). Pain
prevalence ﬁgures in MS from European countries other than Portugal range between 40
and 65%.To our knowledge there is no published data in English on pain in MS in Portugal.
We describe the demographic and clinical characteristics, with an emphasis on pain, of 85
MS patients followed-up in a Portuguese hospital, contributing to pain epidemiology in MS.
Patients were interviewed sequentially after their regular appointments at the MS clinic;
patients with pain completed The Brief Pain Inventory and The McGill Pain Questionnaire
(MPQ). The prevalence of pain found was 34%. Headache and back pain were the most
common anatomical sites described, followed by upper and lower limbs. Intensity of pain
in an 11-point scale was, for the maximum pain intensity 6.7± 1.8, for the minimum pain
intensity 2.2± 2.0, for the mean pain intensity 4.5± 1.5, and for the actual pain intensity
2.4± 2.9. Pain interfered signiﬁcantly with general activity, mood, work, social relations,
and enjoyment of life. All MS patients with pain employed words from both the sensory
and affective categories of the MPQ to describe it. Patient pain descriptions’ included the
word “hot-burning” in 59% of the cases, common in the report of central pain, but neuro-
pathic pain medications were only used by 10% of them. Pain is an important symptom in
Portuguese patients with MS, not only because of the high prevalence found, concordant
with other European countries, but also because of its interference with quality-of-life.
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INTRODUCTION
Early reports stated that pain was an uncommon symptom in
multiple sclerosis (MS), and during the 1980s it was not valued
among the constellation of MS clinical problems (Tourtellote and
Baumhefner, 1983). However, it soon became evident that many
patients with MS suffer from persistent pain during the course of
their disease. Results from European countries other than Portu-
gal (namely, Italy,Belgium,andDenmark) showed pain prevalence
ﬁgures in MS ranging between 40 and 65% (Vermote et al., 1986;
Stenager et al., 1991; Boneschi et al., 2008), and pain has been rec-
ognized as important in the overall health-related quality-of-life
(QoL) of MS patients (Svendsen et al., 2005). Solaro et al. (2004) in
a cross-sectional study that involved 1672 Italian patients further
explored pain frequencies in MS reporting a prevalence of trigem-
inal neuralgia of 2%, Lhermitte’s sign 9%, dysesthetic pain 18.1%,
back pain 16.4% and painful tonic spasms 11%. In the United
States of America and Canada, pain in MS was reported in 66 and
46% of patients, respectively (Ehde et al., 2006; Piwko et al., 2007).
Pain severity in MS was identiﬁed in some studies to be associated
with female sex, increased age, lower educational level, non-stable
MS disease course, longer duration of pain, depression, increased
disability, and greater health care use (Hadjimichael et al., 2007).
Ultimately, a better knowledge about pain characteristics in MS
will lead to improved care and treatment.
In the 1980s the Iberian Peninsula, comprising Portugal and
Spain, was classiﬁed as a low–medium frequency zone for MS
(Kurtzke, 1980). However, current data has revealed otherwise
(Rosati, 2001), and a recent study has shown a MS prevalence
of 46.3 per 100000 in a region of Portugal (De Sá et al., 2006).
Given the particularities of the disease, all MS patients in Portugal
are followed up in specialized MS clinics managed in the largest
tertiary hospitals. The MS clinic of São João Hospital assists 600
patients per year, 10% of which are newly diagnosed MS cases;
these patients come from the northern part of the country, which
has roughly three million inhabitants.
The objective of this study is to characterize Portuguese MS
patients using two tests of pain measure descriptors, and compar-
ing these results with data fromother countries. To our knowledge,
this is the ﬁrst study that has examined pain in Portuguese MS
patients.
MATERIALS AND METHODS
Eighty-ﬁve patients from the universe of patients of the MS clinic
of São João Hospital, Porto, Portugal, participated in the study.
To be included, the patients had to be more than 18 years old and
have a deﬁnitive diagnosis of MS according to the revised McDon-
ald criteria (Polman et al., 2005). Exclusion criterion was serious
cognitive impairment. Patients in follow-up at the clinic were
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identiﬁed and recruited consecutively during the period of 1 year
(2007), after their regular appointments. Eight patients declined to
enter the study (not willing to participate), and four subjects were
excluded based on the study criterion. The project was approved
by the São João Hospital Ethics Committee; informed consent was
obtained from all subjects.
The clinical records of each patient were consulted to obtain
data on age, gender, education level, race/ethnicity, disease dura-
tion, year of diagnosis, MS type (explained ahead), treatments,
and the presence of pain. The course of MS develops broadly
into four disease types: relapsing–remitting, secondary progres-
sive, progressive-relapsing, and primary progressive. The clinical
evolution of MS usually occurs in relapses in the ﬁrst years of
the disease, with remission of the symptoms and signs (relapsing–
remitting), and then becoming progressive with time (secondary
progressive MS). Other subtypes of the disease, more aggressive,
are progressive-relapsing MS (the signs and symptoms of the dis-
ease do not abate completely after each relapse), and primary
progressive MS that lacks the characteristic episodic evolution,
being progressive from the onset. Additionally, the ﬁrst sympto-
matic form of the disease is the denominated clinically isolated
syndrome.
For eachpatient the score of theExpandedDisability Status Scale
(EDSS; Kurtzke, 1983) was determined by a neurologist on the day
of the study session. The short version of the pain questionnaires
The Brief Pain Inventory (BPI; Daut et al., 1983) and The McGill
Pain Questionnaire (MPQ; Melzack, 1987) were administered to
patients who reported pain during the week previous to the study
session.
EXPANDED DISABILITY STATUS SCALE
The EDSS is a method of quantifying disability in MS. The score
is based on neurological testing of eight functional systems: pyra-
midal, cerebellar, brainstem, sensory, bowel and bladder, visual,
mental, and other (Kurtzke, 1983). The EDSS has a possible range
from 0, indicating no disability and normal neurological examina-
tion, to 10, referring to death due to MS. EDSS steps 1.0–3.5 refer
to patients with MS that are fully ambulatory; EDSS steps 4.0–9.5
are deﬁned by the impairment to ambulation. In the present study
EDSS scores were categorized as mild (0–3.5),moderate (4.0–6.0),
and severe (6.5–9.5).
SHORT VERSION OF THE BRIEF PAIN INVENTORY
TheBPIwas developed to evaluate the intensity and impact of pain
in the daily functioning of patients. Osborne et al. (2006) evalu-
ated the psychometric properties of the short version of the BPI in
patients with MS and pain, and concluded that results support the
validity of the modiﬁed versions of the original long form of the
BPI. The short version of the BPI consists of a diagram to record
pain location in a human ﬁgure and scales for pain intensity and
impact evaluation. Pain intensity is registered in numerical scales
that vary from zero (“no pain”) to 10 (“the worst pain possible”).
Impact of pain is measured in relation to how the pain interferes
with general activity, mood, walking ability, work, social relations,
sleep, and enjoyment of life in 11-point scales (“no interference”
to “interferes completely”). Patients are asked as well about their
pain treatment and relief obtained with it.
SHORT VERSION OF THE McGill PAIN QUESTIONNAIRE
The short version of the MPQ evaluates pain dimensions not mea-
sured in BPI by estimating the sensory and affective elements
of pain, both qualitatively and quantitatively (Melzack, 1987).
It consists of 15 words, 11 representing the sensory category of
pain and four representing the affective category of pain, taken
from the long version of the MPQ. Detailed description of the
long version of the MPQ was reported elsewhere (Melzack, 2005).
Pain intensity is classiﬁed for each word contained in the short
version of the MPQ (see Table 3 for a list of words) using a four-
point scale (0=“no pain”, 1=“mild pain”, 2=“moderate pain”,
3=“high pain”). Two scores are obtained from the sum of the
sensory and the affective ratings; the total score is obtained adding
the sensory and affective scores. The short version of the MPQ
also includes a measure for current pain intensity score, which is a
six-point scale from 0=“no pain”, 1=“mild”, 2=“discomforting”,
3=“distressing”, 4=“horrible” to 5=“excruciating”, and a visual
analogue scale.
STATISTICAL ANALYSIS
There was no missing data. Distributions by frequency were gen-
erated for every categorical variable for the descriptive aspects
of the analysis. For homogenous variances, the t test of Student
was used to compare two patient groups (pain and no pain). For
non-homogenous variances, the Mann–Whitney test was adopted.
The Chi-square test was used for comparisons between categorical
variables. Relationships between age, disease duration, neuro-
logic symptom severity (EDSS) and pain intensity were assessed
using Spearman or Pearson correlation coefﬁcients as appropri-
ate. Statistical signiﬁcance was considered for p values inferior
to 0.05. Statistical analyses were performed using SPSS (SPSS
software INC) and results are presented as mean respectively
median± SD.
RESULTS
The demographical characteristics of the MS patient sample
(Table 1) shows that most of the patients were young adults, pre-
dominantly females. The education level was low, and the authors
noted reading literacy problems during the questionnaires’ ﬁlling
by the patients.
Considering the clinical characteristics of the patient sample
(Table 2), median EDSS score was 2. The majority of patients suf-
fered from the relapsing–remitting subtype of the disease, and the
overall distribution of disease characteristics’ was similar to that
described for other European MS patient populations (Alonso and
Hernán, 2008). Eleven percent of the cases were clinically isolated
syndromes, with clinical, laboratorial, and magnetic resonance
imaging results that allowed for MS diagnosis.
Twenty-nine patients of a total of 85 (34%) had pain in the
day and/or the week previous to the study session. Six patients
(2%) reported pain in more than one location. Comparing the
group of MS patients with pain with the group of MS patients
without pain, no difference was found pertaining gender (Chi-
square, p = 0.672), mean age (t test, p = 0.371), EDSS score by
categories (Chi-square, p = 0.995), mean duration of the disease
(in years; Mann–Whitney, p = 0.771), use of disease-modifying
therapy (Chi-square,p = 0.680),ormean education in years (t test,
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Table 1 | Demographic characteristics of the MS patient sample.
Mean (SD, min, max)
Age 39.7 (11.7, 18, 64)
Number of patients (%)
Gender
Male 23 (27)
Female 62 (73)
Education level
4 years or less 22 (26)
6 years 14 (17)
9 years 9 (11)
12 years 23 (27)
More than 12 years 17 (20)
Race/ethnicity
Caucasian 85 (100)
Marital status
Married or living as married 54 (63)
Single 21 (25)
Divorced 9 (11)
Widowed 1 (1)
Table 2 | Clinical characteristics of the MS patient sample.
Mean (SD)
Disease duration in years 10.9 (7.1)
Years since the diagnosis 11.3 (9.7)
Median
EDSS score 2
Number of patients (%)
MS type
Relapsing-remitting 60 (71)
Secondary progressive 15 (18)
Primary progressive 1 (1)
Clinically isolated syndrome 9 (11)
Table 3 | Qualitative pain characteristics: list of words representative
of the sensory and affective dimensions of the short version ofThe
McGill Pain Questionnaire, and percentage of MS patients with pain
that used each word.
Sensory dimension Affective dimension
(% of patients) (% of patients)
Throbbing (0) Tiring-exhausting (94.1)
Shooting (47.1) Sickening (85.4)
Stabbing (70.6) Fearful (52.9)
Sharp (64.7) Cruel-punishing (23.5)
Cramping (0)
Gnawing (41.2)
Hot-burning (58.8)
Aching (64.7)
Heavy (94.1)
Tender (47.1)
Splitting (41.2)
p = 0.241). Age, disease duration or neurologic symptom sever-
ity (EDSS) were not signiﬁcantly correlated with pain intensity
(r = 0.218, r = 0.321, r = 0.092, p> 0.05, respectively).
Twenty-one patients (72%), of the total of 29 patients with
pain in our study, completed the short versions of the pain ques-
tionnaires BPI and MPQ. Considering the results of the BPI on
pain localization, shown in Figure 1, headache and back pain
were the most common anatomical sites described (27%), fol-
lowed by upper (20%) and lower limbs (13%). Experienced pain
was more often superﬁcial (86%) as opposed to deep (14%). Per-
taining to intensity of pain in an 11-point scale (Figure 2), it
was, for the maximum pain intensity 6.7± 1.8, for the minimum
pain intensity 2.2± 2.0, for the mean pain intensity 4.5± 1.5 and
for the actual pain intensity 2.4± 2.9. Sixty-two percent of the
patients were taking pain medications – with a mean relief of 75%
(±28) – and 10% were being treated with drugs for neuropathic
pain (gabapentin, amytriptiline, carbamazepine). The remainder
were being treated with analgesics (paracetamol, caffeine) and/or
non-steroidal anti-inﬂammatory drugs. Interference of pain (in a
scale from 0 to 10 points) with general activity was 6.3± 4.1, with
FIGURE 1 | Pain localization. Data obtained from the short version of the
Brief Pain Inventory.
FIGURE 2 | Pain intensity in an 11-point scale of the Brief Pain
Inventory (0=“no pain” e 10=“the worst pain possible”).The
horizontal line deﬁnes the median point of the scale (5).
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FIGURE 3 | Pain interference with general activity, mood, walking
ability, work, social relations, sleep, and enjoyment of life in an
11-point scale of the Brief Pain Inventory (0=“no interference” e
10=“interferes completely”).The horizontal line deﬁnes the median point
of the scale (5).
mood was 7.2± 2.8, with walking was 4.5± 3.8, with work was
6.3± 3.6, with relations with others was 5.1± 4.2, with sleep was
4.6± 3.8 and with enjoyment of life was 7.2± 3.2 (Figure 3).
The patients’ subjective descriptions of their pain using the
words from the short version of the MPQ are detailed in Table 3.
The sensory and affective scores of the MPQ were, respectively,
12.1 and 6.2; the total score was 22.3. Actual pain intensity in a
six-point scale was 1.6± 0.4. All the patients used more than one
word to describe their pain, and always used words from both
categories, sensory and affective. The words most frequently used
were“heavy”and“tiring-exhausting” in 91.4% of the patients, and
“hot-burning” in 58.8% of the cases.
DISCUSSION
The prevalence of pain found in this study, 34%, is in accordance
with the range of results from other European countries (Clif-
ford and Trotter, 1984; Vermote et al., 1986; Stenager et al., 1991).
However, there is some variability that might be related to differ-
ences/heterogeneity between the studied populations, and/or vari-
ation in the methodologies used. For example, studies differ in the
sources from which the samples were drawn (e.g., hospital, ward,
clinic, community, MS organizations) as well as in the sampling
methodologies used (e.g., random, convenience). In our study,
pain characterization by the patients was done reporting to pain
experienced in the week previous to the study session, avoiding
memory and other cognitive biases and/or symptom ﬂuctuation
that could interfere with the results. Headache was included in
the evaluation of pain location (which was not reported in other
studies; Clifford and Trotter, 1984; Stenager et al., 1991), because
there is evidence that it may be secondary to MS disease processes
(Archibald et al., 1994). However, including patients that reported
pain in the week before the study visit may have, on the other
hand, introduced a bias on the prevalence of episodic pains like
headache. The MS diagnostic criteria used in the present study,
from the International Panel on the Diagnosis of Multiple Sclero-
sis of 2001, and revised in 2005 (Polman et al., 2005), may have
also had an impact in our results, especially when compared with
older studies, because the actual criteria have more sensitivity and
speciﬁcity, and allow earlier disease diagnosis (Poser et al., 1983;
CHAMPS Study Group, 2002; Dalton et al., 2002). In this way,
we strongly believe patients with other diseases besides MS were
excluded, a possible confounder of the prevalence ﬁgures.
The ﬁnding that the head, back, and upper limbs were the most
common pain sites in our Portuguese MS population is consis-
tent with other studies (Ehde et al., 2006). Similarly to Ehde et al.
(2006) and Stenager et al.’s (1991) results, we have not found an
association neither between pain intensity and MS duration (as
measured by the time since the beginning of the symptoms, and
not by the time since initial diagnosis) nor between pain intensity
and functional impairment (EDSS score). Results in the literature
are dissimilar, maybe reﬂecting once more methodological issues
or population discrepancies. The dissimilarity may additionally
reﬂect heterogeneity of pain mechanisms in MS: it is known that
just one lesion in a key area of the central nervous system can cause
a neuropathic pain syndrome, implying that this type of pain can
appear at any stage of MS. On the other hand, the higher the func-
tional impairment during disease progression, the more likely is
pain from the nociceptive type to appear, secondary for exam-
ple to spasticity and mobility problems, making these associations
difﬁcult, and probably even not useful to make.
Regarding BPI results, only 10% of the patients were taking
drugs for neuropathic pain treatment for pain relief. On the other
hand, patient pain descriptions’ from the MPQ included the word
“hot-burning” in 58.8% of the cases, a word commonly used in
the report of central pain. Considering these results and the fact
that neuropathic pain is referred in the literature as the most com-
mon pain syndrome in MS (Fischer et al., 1999; Osterberg et al.,
2005), our patients are probably being undertreated for their pain
syndromes.
Pain interfered meaningfully with general activity,mood,work,
relations with others, and enjoyment of life, that is, ﬁve of the
seven parameters used in the QoL assessment. According to Daut
et al. (1983), pain intensity or interference in QoL can be con-
sidered meaningful above the median point 5 of the BPI scales. In
view of this,maximum pain intensity was meaningful in our study
(Figure 2), as well as pain interference with general activity,mood,
work, relations with others, and enjoyment of life (Figure 3). To
our knowledge, only in a study by Ehde et al. (2006) was the BPI
used as a pain and QoL measure in MS patients. The average level
of overall pain interference with QoL was signiﬁcantly higher in
our study (t test, p< 0.001), further supporting the idea that pain
has a major impact in the QoL of our Portuguese sample of MS
patients.
Pain revealed to be an important symptom in this sample of
85 MS patients, not just for the reason of the high prevalence
found – in line with results from other European countries – but
also because of the major interference of pain with the QoL of
these patients. Given that the majority of patients were young
adults and had a low education level and literacy [corroborated
by the Organization for Economic Co-operation and Development
(OECD); www.oecd.org/dataoecd/44/35/14735458.pdf, accessed
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in June 6, 2009], this may have consequences in an individual
perspective,possiblymaking itmore difﬁcult for patients to under-
standMSdiagnosis, prognosis, impact in daily life, andmedication
regimes, and, consequently, reducing compliance. In light of our
results, we believe that an extra effort should be made to better
identify MS patients with clinically meaningful pain syndromes in
order to properly manage and treat these patients attenuating the
devastating consequences of chronic pain.
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